Effect of Inhaled Nitric Oxide on Outcomes in Children With Acute Lung Injury: Propensity Matched Analysis From a

Punkaj Gupta1, Troy Richardson, Matthew Hall

  • 11Division of Pediatric Cardiology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR.2Children's Hospital Association, Overland Park, KS.3Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.4Virtual PICU Systems, LLC, Los Angeles, CA.5Division of Critical Care Medicine, Department of Pediatrics and Anesthesiology, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, CA.

Insights

Inhaled nitric oxide did not improve mortality in children with acute lung injury. This treatment was linked to increased hospital resource use and higher costs.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Medicine
  • Clinical Pharmacology

Background:

  • Acute lung injury (ALI) in children presents significant challenges in critical care.
  • Inhaled nitric oxide (iNO) is a therapeutic gas used in respiratory conditions.
  • The efficacy of iNO in pediatric ALI remains a subject of investigation.

Purpose of the Study:

  • To evaluate the impact of inhaled nitric oxide on mortality and other outcomes in pediatric patients with acute lung injury.
  • To analyze the association between iNO administration and resource utilization in this patient population.

Main Methods:

  • Retrospective analysis of linked data from two national pediatric databases (2009-2014).
  • Inclusion of pediatric patients (<18 years) on mechanical ventilation for ALI.
  • Propensity score matching to compare outcomes between patients receiving iNO (≥24 hours) and those not receiving iNO.

Main Results:

  • A total of 20,106 patients were analyzed; 859 (4.3%) received iNO.
  • After propensity score matching, no significant difference in mortality was observed between the iNO and no-iNO groups (22.3% vs 20.2%).
  • The iNO group experienced significantly worse outcomes, including fewer ventilation-free days, longer mechanical ventilation duration, longer ICU and hospital stays, and higher hospital costs.

Conclusions:

  • Inhaled nitric oxide administration in children with acute lung injury is not associated with improved survival.
  • iNO use in this population correlates with increased hospital resource utilization and elevated healthcare costs.
  • Further research may be needed to identify specific pediatric ALI subgroups who might benefit from iNO therapy.
Abstract

Related Concept Videos

Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
2.0K
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
3.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K